All News Kintor Pharmaceutical Limited

Equities

9939

KYG5273B1077

Market Closed - Hong Kong S.E. Other stock markets 04:08:20 2024-04-26 am EDT			5-day change	1st Jan Change
0.96 ^HKD	+2.13%		+10.34%	-41.10%

Apr. 22	Kintor Pharmaceutical Limited Announces Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China Reaches Primary Endpoint	CI
Apr. 22	Kintor Pharmaceutical Concludes Phase II Clinical Trial for Androgenic Alopecia Treatment	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kintor Pharmaceutical Limited Announces Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China Reaches Primary Endpoint	Apr. 21	CI
Kintor Pharmaceutical Concludes Phase II Clinical Trial for Androgenic Alopecia Treatment	Apr. 21	MT
Kintor Pharmaceutical Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Kintor Pharmaceutical's Trial of Androgenetic Alopecia Drug Cleared by Chinese Regulator	Feb. 01	MT
Kintor Pharmaceutical Limited Announces Phase Ib/III Clinical Trial of KX-826 and Minoxidil Combination Therapy for the Treatment of Men Adults Receives Clearance by China NMPA	Feb. 01	CI
Kintor Pharmaceutical's Phase 3 Trial for Alopecia Treatment Promotes Hair Growth; Shares Plunge 30%	Nov. 26	MT
Kintor Pharmaceutical Limited Announces Results of Phase III Clinical Trial of KX-826 Topline Treatment for Men Androgenetic Alopecia	Nov. 26	CI
Kintor Pharmaceutical : Pharma Announces Publication of Phase Ib/II Data from GT90001 and Nivolumab Combination Therapy for Advanced HCC in BMC Medicine	23-10-27	PU
Kintor Pharmaceutical Limited Announces the Approval for Phase II Clinical Trial of Hedgehog/SMO Inhibitor GT1708F for Treatment of IPF in China	23-10-11	CI
Kintor Pharmaceutical : Pharma Announces the Approval of Phase II Clinical Trial of Hedgehog/SMO Inhibitor GT1708F for Treatment of IPF in China	23-10-11	PU
Kintor Pharmaceutical : Pharma Announces 2023 Interim Results and Recent Business Highlights	23-08-28	PU
Kintor Pharmaceutical Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Kintor Pharmaceutical Completes Enrollment for Alopecia Drug Trial	23-08-23	MT
Kintor Pharma Announces Completion of Patient Enrollment in Phase Ii Clinical Trial of Gt20029 for Treatment of Androgenetic Alopecia in China	23-08-22	CI
Kintor Pharmaceutical : Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China	23-08-22	PU
Kintor Pharma Announces Completion of First Patient Enrollment in KX-826 Long-term Safety Phase III Trial for Treatment of AGA	23-07-20	AQ
Kintor Pharmaceutical Enrolls First Patient for Phase III of Alopecia Drug Trial	23-07-20	MT
Kintor Pharmaceutical Limited Announces Completion of First Patient Enrollment in Long-Term Safety Trial of Kx-826	23-07-19	CI
Kintor Pharmaceutical Limited Appoints Ming Ming Cheung as Joint Company Secretary	23-05-12	CI
Kintor Pharmaceutical's Completes US Phase 2 Trials of Alopecia Treatment; Shares Fall 4%	23-05-12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Kintor Pharmaceutical Limited

Equities

9939

KYG5273B1077

All News

Filters